Skip to main content Skip to navigation Skip to mobile navigation Skip to accessibility tools

Switchboard0151 556 5000

24/7 hotline (treatment side-effects)
The Clatterbridge Cancer Centre NHS Foundation Trust

You can search our website using your chosen language.

Private care
Charity
  • Home
  • Patients and visitors
    • Patients and visitors
    • Treatment and care
      • Treatment and care
      • Treatments
      • Cancer types
      • Consultants
      • Your first visit
      • Hospital appointments
      • Video appointments
      • Inpatients
      • Health advice - eating well, exercise and cancer care
        • Health advice - eating well, exercise and cancer care
        • Physical activity and cancer care
        • Eating well and cancer care
      • Clinical trials
      • Visitors
      • Getting here
      • Isle of Man patients
      • Private and international patients
      • Advice and support
        • Advice and support
        • Interpreters and help with additional needs
        • Cancer information and support centres
        • Benefits advice
        • Arts programme
        • Chaplaincy
      • Feedback, compliments and complaints
      • Request your records (subject access requests)
        • Request your records (subject access requests)
        • Request your records - easy-read information
        • Subject Access Request Form
      • Referral and second opinion
      • Patient information leaflets
        • Patient information leaflets
        • Lung cancer nursing team
        • Radiotherapy
        • Contact x-ray brachytherapy for rectal cancer (Papillon)
        • You and your gastrostomy feeding tube
        • Insertion of a rectal spacer for radiotherapy
        • High Dose Rate (HDR) brachytherapy to the vaginal vault
        • Proton beam therapy to the eye
        • High Dose Rate (HDR) brachytherapy to the skin
        • High Dose Rate (HDR) brachytherapy for cancer of the cervix
        • Treatment of prostate cancer with high dose rate (HDR) brachytherapy
        • Treatment of prostate cancer with high dose rate (HDR) brachytherapy in combination with external beam radiotherpay (EBRT)
        • Immunotherapy
        • Nasogastric tube - Being discharged with a nasogastric tube
        • You and your Totally Implanted Vascular Access Device (TIVAD) - Portacath
        • You and your PICC line
        • Eating well and coping well with side-effects on a vegan diet
        • Low residue diet information
        • Adding extra nourishment to your food when you have diabetes
        • Eating well and coping well with side-effects
        • Proton beam therapy: Frequently asked questions and other useful information
        • Hepato-pancreato-biliary (HPB) nursing and support team
        • Arthralgia
        • Immune-related hepatitis
        • Skin care advice for patients on immunotherapy treatment
        • Infliximab - frequently asked questions
        • Cancer of Unknown Primary
        • Your nasogastric (NG) feeding tube and medication
        • Lymphoedema advice
        • What to do after an extravasation
        • Scalp cooling - a guide for patients
        • Breast cancer nursing team
        • Prostate cancer nursing and support team
        • Skin cancer nursing team
        • Upper gastrointestinal (UGI) nursing and support team
        • Teenage and Young Adult service
        • Choosing a wig
        • Your cancer treatment in your community
        • Liver surveillance service
        • Supported self management and patient-directed open access - MGUS
        • Sick day rules for people on basal bolus or pre-mixed insulin
        • Patient information for referral for consideration of SABR
        • Simple lymphatic drainage - head and neck
        • Advice to patients with a cardiac implantable electronic device – pacemakers or ICDS
        • How can we help? (Holistic Needs Assessment)
        • Pituitary and craniopharyngioma – radiotherapy
        • My Medical Record - information for patients
        • Lenalidomide (Revlimid) switch to generic equivalents
        • Lidocaine 2% mouthwash
      • Communicating with patients
    • Our hospitals
    • Our services
    • Consultants
    • Get involved
  • Research and innovation
    • Research and innovation
    • Research
      • Research
      • Welcome to research
      • Our research
      • Research sponsorship
      • Clinical trials
      • Meet the team
      • Research partnerships
      • Jargon buster
      • Biobank
      • Research Strategy
      • How you can get involved
      • Research passports, honorary research contracts and letters of access
      • Research news
    • Innovation
      • Innovation
      • Welcome to innovation
  • Work with us
    • Work with us
    • Vacancies
    • Recruitment - joining our team
    • Your career: Our recruitment pack
    • Staff benefits: why choose us
      • Staff benefits: why choose us
      • Staff networks
      • Staff Excellence Awards 2023
        • Staff Excellence Awards 2023
        • Staff Excellence Awards 2022
    • Roles and careers we offer
      • Roles and careers we offer
      • Healthcare science
      • Physiotherapy
    • Staff profiles
    • Staff bank
    • Living locally
    • Apprenticeships
    • Work experience
    • Volunteering
    • Get involved
    • Staff privacy notice
  • Professionals
    • Professionals
    • Education and training
      • Education and training
      • Clinical education courses
      • Clinical scientist training
      • Communication skills
      • FRCR Part 2b mock exam
      • Nursing career pathway
        • Nursing career pathway
        • Nursing career pathway and competency framework toolkit
      • Papillon
    • Clinical guidance
      • Clinical guidance
      • Acute oncology (AO) and CUP guidance
      • Immunotherapy guidance
      • Metastatic spinal cord compression (MSCC) guidance
      • Catheter and line care guidance
      • SACT protocols and guidance
        • SACT protocols and guidance
        • All protocols and guidance
        • Breast
        • CNS
        • Gastrointestinal
        • Germ cell
        • Gynaecological
        • Haematology
        • Head and neck
        • Lung
        • Miscellaneous
        • Renal
        • Sarcoma
        • Skin
        • Supportive therapies
        • Urology
      • Referring patients
      • Haemato-Oncology (haematology) clinical guidance
    • Work with us
  • About us
    • About us
    • Who we are
    • Vision and strategy
      • Vision and strategy
      • Vision, mission and values
      • Strategies and plans
        • Strategies and plans
        • Five Year Strategic Plan
        • Green Plan
        • Innovation Strategy
        • People Commitment
        • Patient Experience Commitment
        • Research Strategy
        • Quality Improvement and Learning Strategy
    • How we're run
      • How we're run
      • Trust Board
        • Trust Board
        • Trust Board meetings and papers
      • Procurement
      • Council of Governors
        • Council of Governors
        • Our governors
      • Membership of our Trust
    • Who we work with
    • How we're doing
      • How we're doing
      • Our reports and accounts
      • Care Quality Commission
      • Equality, diversity and inclusion
      • Achievements and accreditations
    • Our services
    • Our history
    • Publications and documents
    • Freedom of Information (FOI)
    • News
    • Get involved
  • Contact us
  • Clatterbridge Cancer Centre on Facebook
  • Clatterbridge Cancer Centre on Instagram
  • Clatterbridge Cancer Centre on X
  • Clatterbridge Cancer Centre on Youtube
  • Clatterbridge Cancer Centre on LinkedIn

Carbapenemase-producing Enterobacterales (CPE)

You are here:

  1. Home
  2. Patients and visitors
  3. Treatment and care
  4. Patient information leaflets
  5. Carbapenemase-producing Enterobacterales (CPE)

On this page…

What does ‘Carbapenemase-producing Enterobacterales’ (CPE) mean?

Enterobacterales are bacteria that are normally present in the intestines and faeces and do not cause any harm there. This is called "colonisation".  

If bacteria get into the wrong places, such as the bladder or bloodstream, they can cause infections.

Carbapenems are a group of antibiotics. 

Carbapenemases are enzymes (chemicals) made by some strains of these bacteria that allow them to destroy carbapenem antibiotics, so the bacteria become resistant to these antibiotics.

These are called 'Carbapenemase-Producing Enterobacterales' or CPEs.

Why is carbapenem resistance important?

Carbapenems antibiotics are administered directly into the bloodstream typically in a hospital setting.

In the past, doctors have relied on this antibiotic group to successfully treat certain infections. Therefore, the spread of resistant bacteria can pose a problem in hospitals with large numbers of vulnerable patients.

Does CPE colonisation need to be treated the same as a blood stream infection?

If you are a carrier of CPE, no treatment is required. However, if bacteria do cause an infection, antibiotics are needed.

How is CPE spread?

If hospitalised patients carry CPE bacteria, these bacteria can enter the ward environment by different routes such as through direct physical contact.

So, washing hands after using the toilet and before meals is really important to stop CPE from spreading. 

How do we know if someone is colonised with CPE? 

It isn't usually known that a patient is CPE colonised until after a CPE test is performed to identify the bacteria.

Screening is undertaken:

  • If the patient has been transferred from another hospital in the UK or abroad
  • For patients hospitalized within the last 12 months
  • If the patient is known to be colonised with CPE
  • If the patient has been a known contact of someone with CPE colonisation and has had prolonged contact with the individual

How is CPE testing carried out?

A rectal swab is required for screening.

Rectal swabs are gently inserted directly into the rectum (anus) and removed with a twist. There may be some pressure as the swab is inserted into the rectum, but the test is usually painless.

Alternatively, you may be asked to provide a stool sample (stool sample). If you have a colostomy or stoma, swabs are also taken from this site at the same time.  

The swab will be sent to the laboratory and usually we will have the results within 2-3 days.

If the results are negative, no further action is necessary unless long-term hospitalisation is required. Further testing may be required as recommended by the infection control team.

Any patient who stays in the hospital for over 30 days will have another CPE test and this will be repeated at 30 day intervals to ensure that colonisation isn't missed. 

What if the result is positive?

Your doctor or nurse will explain your result further to you and give you an information leaflet to read. Staff will wear aprons and gloves when entering your room. No treatment is required unless you have an infection that requires antibiotics.

How can I prevent the spread of CPE?

Wash your hands with soap and water:

  • After going to the toilet
  • Before eating and drinking
  • Before and after leaving your room or departments within the hospital

It’s important to maintain high levels of personal hygiene during your inpatient admission. This reduces the risk of developing or spreading lots of different infections. The nursing staff are able to assist with support with personal hygiene if you are struggling to complete this on your own. This includes wearing fresh clothes every day or changing clothing if it becomes soiled. 

It’s important that all patients and staff avoid sitting on patients beds. Patient should only sit or sleep in their own bed in the hospital to reduce the spread of micro-organisms. 

Laundry

If family or friends are washing your clothing while you are in hospital please advise them to wash the laundry separately from other clothing at 60°C.  

Can I have visitors during my admission if I have CPE?

Yes, you can have visitors. It’s advised that visitors wash their hands with soap and water when entering and exiting the room.

Aprons and gloves are not required for visitors to wear unless they are supporting with personal hygiene and care delivery. 

If your visitor is visiting another sick person in the hospital, ask them to visit you last.

What if someone is pregnant?

There are no additional risks to any individual who is pregnant when visiting a patient with this infection type. 

What should I do when I am discharged home?

It is advisable to continue to wash your hands with soap and water often, particularly after using the toilet and when preparing food.

Once you are discharged home, there are no activities restricted to you in the community due to you having a CPE positive result in hospital.  

  
For further information contact the Infection Prevention and Control Team on 07387546017.
 

Cancer Voices logo

This information has been reviewed by Cheshire and Merseyside Cancer Voices to check it is easy to understand. Cheshire and Merseyside Cancer Voices is a panel of cancer patients who volunteer to read NHS information to make sure it makes sense to people. They have been brought together by Cheshire and Merseyside Cancer Alliance. 

This information is produced by staff at The Clatterbridge Cancer Centre. It is not sponsored or influenced in any way.

We make every effort to ensure information is accurate and complete - we hope that it will add to any professional advice you have had. Information is based on evidence and accepted guidelines (where appropriate). We review and update it regularly. If you are worried about your health, please tell your clinical team.

Size and colour

You can click 'Show accessibility tools' at the bottom of this page to change the text size and colour contrast.

Languages

You can use 'Google Translate' by clicking 'Show accessibility tools' at the bottom of this page. Google Translate will translate information into other languages but it is not under our control and we cannot guarantee its accuracy. You can get a professionally translated copy of our patient information free of charge by calling us on 0151 318 8805.  

Other formats

Call us on 0151 318 8805 if you need information in another format such as Braille or have any other questions about accessibility. 

Printed versions

You can use the 'Print this page' button to save a PDF copy of our patient information pages. 

Issue date: August 2025

Issue number: 1.0

Reference: LICCPEL

Review date: August 2028

More in this section...

Lung cancer nursing team

Radiology and diagnostic imaging

Lymphoma and CLL team

Radiotherapy

Contact x-ray brachytherapy for rectal cancer (Papillon)

You and your gastrostomy feeding tube

Insertion of a rectal spacer for radiotherapy

High Dose Rate (HDR) brachytherapy to the vaginal vault

Proton beam therapy to the eye

High Dose Rate (HDR) brachytherapy to the skin

High Dose Rate (HDR) brachytherapy for cancer of the cervix

Treatment of prostate cancer with high dose rate (HDR) brachytherapy

Treatment of prostate cancer with high dose rate (HDR) brachytherapy in combination with external beam radiotherapy (EBRT)

Immunotherapy

Nasogastric tube - Being discharged with a nasogastric tube

You and your Totally Implanted Vascular Access Device (TIVAD) - Portacath

You and your PICC line

Eating well and coping well with side-effects on a vegan diet

Low residue diet information

Adding extra nourishment to your food when you have diabetes

Eating well and coping with side-effects

Proton beam therapy: Frequently asked questions and other useful information

Hepato-pancreato-biliary (HPB) nursing and support team

Arthralgia

Immune-related hepatitis

Skin care advice for patients on immunotherapy treatment

Infliximab - frequently asked questions

Cancer of Unknown Primary

Your nasogastric (NG) feeding tube and medication

Lymphoedema advice

What to do after an extravasation

Scalp cooling - a guide for patients

Breast cancer nursing team

Prostate / Bladder Cancer Nursing and Support Team

Skin cancer nursing team

Upper gastrointestinal (UGI) nursing and support team

Teenage and Young Adult service

Choosing a wig

Your cancer treatment in your community

Liver surveillance service

Supported self management and patient-directed open access - MGUS

Sick day rules for people on basal bolus or pre-mixed insulin

Patient information for referral for consideration of SABR

Advice to patients with a cardiac implantable electronic device – pacemakers or ICDS

How can we help? (Holistic Needs Assessment)

Pituitary and craniopharyngioma – radiotherapy

My Medical Record - information for patients

Lenalidomide (Revlimid) switch to generic equivalents

Lidocaine 2% mouthwash

Driving and diabetes

Hypos (hypoglycaemia)

Sick day rules for people on once-daily long-acting insulin

Safe sharps disposal

Information for people with Type 2 diabetes commencing steroids

What are ketones?

Chemotherapy group pre-assessment sessions

Etoposide

Temozolomide

Procarbazine

Lomustine (CCNU)

Temozolomide with Radiotherapy

Hospital water safety

Going home after your Stem Cell Transplant

Going home after CAR-T therapy

Safer Eating – Guidance for patients with a weakened immune system

Campylobacter

Clostridioides difficile Infection (CDI)

Vancomycin Resistant Enterococci (VRE)

Viral Gastroenteritis (Norovirus)

Information for Related Blood Stem Cell Donors

CAR-T cell therapy

Radiotherapy skin reactions

The Clatterbridge Cancer Centre Hotline

  • Aintree
    Telephone: 0151 556 5958
  • Liverpool
    Telephone: 0151 556 5000
  • Wirral
    Telephone: 0151 556 5000
  • Other clinics
    Telephone: 0151 556 5000
  • Paddington
    Telephone: 0151 556 5000
  • Clatterbridge Cancer Centre on Facebook
  • Clatterbridge Cancer Centre on Instagram
  • Clatterbridge Cancer Centre on X
  • Clatterbridge Cancer Centre on Youtube
  • Clatterbridge Cancer Centre on LinkedIn
  • Compliments and complaints
  • Vacancies
  • Accessibility statement
  • Privacy
  • Freedom of information
  • CQC rating

Accessibility tools

Text size:
Contrast:

Created by Frank Ltd.

Return to header
Last accessibility toolbar action: none available